Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas-ko ikertzaileekin lankidetzan egindako argitalpenak (139)

2024

  1. A new mutation in the Parkinson's-related FBXO7 gene impairs mitochondrial and proteasomal function

    FEBS Journal

  2. Involvement of CB1 and CB2 receptors in neuroprotective effects of cannabinoids in experimental TDP-43 related frontotemporal dementia using male mice

    Biomedicine and Pharmacotherapy, Vol. 174

  3. The CB1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls

    EMBO Molecular Medicine, Vol. 16, Núm. 4, pp. 755-783

2023

  1. Control of a hippocampal recurrent excitatory circuit by cannabinoid receptor-interacting protein Gap43

    Nature Communications, Vol. 14, Núm. 1

  2. Disease-modifying effects of cannabidiol, β-caryophyllene and their combination in Syn1-Cre/Scn1aWT/A1783V mice, a preclinical model of Dravet syndrome

    Neuropharmacology, Vol. 237

  3. Endocannabinoid signaling in glioma

    GLIA, Vol. 71, Núm. 1, pp. 127-138

  4. Endocannabinoid-Binding Receptors as Drug Targets

    Methods in molecular biology (Clifton, N.J.), Vol. 2576, pp. 67-94

  5. Fatty acids fuelling astroglia and beyond

    Nature Metabolism

  6. Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer

    Nature Communications, Vol. 14, Núm. 1

  7. Preclinical investigation in FAAH inhibition as a neuroprotective therapy for frontotemporal dementia using TDP-43 transgenic male mice

    Journal of neuroinflammation, Vol. 20, Núm. 1, pp. 108

  8. Retinal Tissue Shows Glial Changes in a Dravet Syndrome Knock-in Mouse Model

    International Journal of Molecular Sciences, Vol. 24, Núm. 3

  9. Selective inhibition of cannabinoid CB1 receptor-evoked signalling by the interacting protein GAP43

    Neuropharmacology, Vol. 240

  10. The Cannabigerol Derivative VCE-003.2 Exerts Therapeutic Effects in 6-Hydroxydopamine-Lesioned Mice: Comparison with The Classic Dopaminergic Replacement Therapy

    Brain Sciences, Vol. 13, Núm. 9

  11. The GRP78-PERK axis contributes to memory and synaptic impairments in Huntington's disease R6/1 mice

    Neurobiology of Disease, Vol. 184

2022

  1. Cannabinoid CB1 receptor expression in oligodendrocyte progenitors of the hippocampus revealed by the NG2-EYFP-knockin mouse

    Frontiers in Neuroanatomy, Vol. 16

  2. Cannabinoid CB1 receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in mice

    Cell Death and Disease, Vol. 13, Núm. 7

  3. Editorial: Cannabinoids as potential treatment for neurological diseases

    Frontiers in Neuroscience

  4. New Statement about NRF2 in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

    Biomolecules, Vol. 12, Núm. 9

  5. Preclinical investigation of β-caryophyllene as a therapeutic agent in an experimental murine model of Dravet syndrome

    Neuropharmacology, Vol. 205

  6. TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy

    Journal of Medicinal Chemistry, Vol. 65, Núm. 2, pp. 1585-1607